The stock has plenty of potential once its diluted. They are already registered for JP Morgan HealthCare Conference, 2010, ASCO 2010, World Melanoma in Germany 2010., and will probably be at the Bio CEO 2010. There are 1 or 2 I left out. Just hold out till
Genta does its thing. Then buy like crazy